Literature DB >> 11751445

Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.

M T Goodman1, K McDuffie, B Hernandez, L R Wilkens, C C Bertram, J Killeen, L Le Marchand, J Selhub, S Murphy, T A Donlon.   

Abstract

Epidemiological studies have been inconsistent regarding a role for folate in the etiology of cervical dysplasia. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, which is involved in the methylation of homocysteine to methionine. A common variant of this enzyme, resulting from a 677C-->T (Ala-->Val) substitution in the gene, has been shown to have reduced activity and is associated with mild hyperhomocysteinemia. A multiethnic case-control study was used to examine the association of dietary folate and MTHFR genotype with the odds ratios (ORs) for cervical dysplasia among women identified from several clinics on Oahu, Hawaii, between 1992 and 1996. We collected blood samples for DNA extraction, cervical smears for cytological diagnosis, exfoliated cervical cells for human papillomavirus (HPV) DNA testing, and personal interviews from 150 women with squamous intraepithelial lesions (SILs) and from 179 women with cytologically normal (Pap) smears. We found a positive, monotonic trend (P = 0.02) in the ORs for cervical SILs associated with the number of variant MTHFR T alleles, after multivariate adjustment. Women with the heterozygous CT genotype had twice the risk of cervical SILs [OR, 2.0; 95% confidence interval (CI), 1.1-3.7], and women with the homozygous TT genotype had almost three times the risk of SILs (OR, 2.9; 95% CI, 1.0-8.8) compared to women with the homozygous MTHFR CC genotype. The dietary intakes of folate, vitamin B(6), and vitamin B(12) were inversely related to the ORs for cervical SILs, after adjustment for HPV DNA and other confounders. The OR among women in the highest quartile compared with women in the lowest quartile of folate intake was 0.3 (95% CI, 0.1-0.7; P for trend = 0.002). Women with the variant T allele and folate intakes below the median were at significantly elevated risk of cervical SILs (OR, 5.0; 95% CI, 2.0-12.2) compared to women with CC alleles and folate intakes above the median. HPV infection was a strong risk factor for cervical dysplasia, particularly among women with the variant T allele (OR, 46.6; 95% CI, 15.9-136.2). All associations of MTHFR genotype with the ORs for cervical SILs were independent of other risk factors under study. These findings suggest that the MTHFR T allele and reduced dietary folate may increase the risk for cervical SILs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751445

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Authors:  Wen-Lei Zhuo; Liang Zhang; Jun-Jun Ling; Yi Zhu; Zheng-Tang Chen
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

2.  Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease.

Authors:  Margreet Zoodsma; Ilja M Nolte; Martin Schipper; Elvira Oosterom; Gerrit van der Steege; Elisabeth G E de Vries; Gerard J te Meerman; Ate G J van der Zee
Journal:  Hum Genet       Date:  2005-01-06       Impact factor: 4.132

3.  Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status.

Authors:  Chandrika J Piyathilake; Maria Azrad; Maurizio Macaluso; Gary L Johanning; Phillip E Cornwell; Edward E Partridge; Douglas C Heimburger
Journal:  Nutrition       Date:  2007-02-14       Impact factor: 4.008

4.  Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia.

Authors:  Erin M Siegel; Jason L Salemi; Luisa L Villa; Alex Ferenczy; Eduardo L Franco; Anna R Giuliano
Journal:  Gynecol Oncol       Date:  2010-06-18       Impact factor: 5.482

5.  Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis.

Authors:  Ugur Deligezer; Ebru Akisik; Nejat Dalay
Journal:  Mol Diagn       Date:  2003

6.  Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.

Authors:  Li-Na Mu; Wei Cao; Zuo-Feng Zhang; Lin Cai; Qing-Wu Jiang; Nai-Chieh You; Binh Yang Goldstein; Guo-Rong Wei; Chuan-Wei Chen; Qing-Yi Lu; Xue-Fu Zhou; Bao-Guo Ding; Jun Chang; Shun-Zhang Yu
Journal:  Cancer Causes Control       Date:  2007-05-15       Impact factor: 2.506

7.  Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.

Authors:  Ya Li Luo; Ping Ye; Qiong Hua Zhang; Ting Ting Hu; Min Hong Luo; Mei Qing Li; Qing Chen
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.

Authors:  Shuyu Long; Xingliang Yang; Xiaojiao Liu; Pei Yang
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

9.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

10.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.

Authors:  Anca Botezatu; Demetra Socolov; Iulia V Iancu; Irina Huica; Adriana Plesa; Carmen Ungureanu; Gabriela Anton
Journal:  J Cell Mol Med       Date:  2013-02-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.